Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease

World Journal of Gastroenterology

Volumn 12, Issue 2, 2006, Pages 240-245

  Peretz, Gil ^a   Link, Gabriela ^b   Pappo, Orit ^a   Bruck, Rafael ^c,d   Ackerman, Zvi ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bile duct ligation; Hepatic activity index; Iron; Phlebotomy; Rat

Indexed keywords

ALBUMIN; IRON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; IRON DEFICIENCY; IRON DEPLETION; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; LIVER LEVEL; LIVER NECROSIS; LIVER WEIGHT; MALE; NONHUMAN; PHLEBOTOMY; PORTAL HYPERTENSION; RAT; SCORING SYSTEM; TISSUE DISTRIBUTION;

EID: 33644759724     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i2.240     Document Type: Article

References (55)

1. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999; 19:129-140
2. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis incirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-888
3. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley KV. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29: 257-262
4. Kayali Z, Ranguelov R, Mitros F, Shufelt C, Elmi F, Rayhill SC, Schmidt WN, Brown KE. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis. Liver Int 2005; 25: 41-48
5. Gardi C, Arezzini B, Fortino V, Comporti M. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol 2002; 64: 1139-1145
6. Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996; 16: 13-30
7. Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical - mediated process? Hepatology 1990; 11: 127-137
8. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22: 287-305
9. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19: 1262-1271
10. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 2003; 531: 81-92
11. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 449-456
12. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318
13. Sherrington CA, Olynyk JK. Iron as a cofactor in chronic hepatitis C infection. Liver 2002; 22: 187-189
14. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 2003; 30: 137-144
15. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003; 124: 318-326
16. Bassett SE, Di Bisceglie AM, Bacon BR, Sharp RM, Govindarajan S, Hubbard GB, Brasky KM, Lanford RE. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology 1999; 29: 1884-1892
17. Martinelli AL, Ramalho LN, Zucoloto S. Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease. J Gastroenterol Hepatol 2004; 19: 91-98
18. Arezzini B, Lunghi B, Lungarella G, Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int J Biochem Cell Biol 2003; 35: 486-495
19. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96: 620-630
20. Olynyk J, Hall P, Reed W, Williams P, Kerr R, Mackinnon M. A long-term study of the interaction between iron and alcohol in an animal model of iron overload. J Hepatol 1995; 22: 671-676
21. Toniutto P, Fabris C, Bortolotti N, Minisini R, Avellini C, Fumo E, Pirisi M. Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation. J Hepatol 2004; 41: 307-311
22. George DK, Ramm GA, Powell LW, Fletcher LM, Walker NI, Cowley LL, Crawford DH. Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut 1998; 42: 715-720
23. Anderson GJ. Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999; 14: 105-108
24. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 931-939
25. Carlo C, Daniela P, Giancarlo C. Iron depletion and response to interferon in chronic hepatitis C. Hepatogastroenterology 2003; 50: 1467-1471
26. Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 2000; 31: 730-736
27. Yano M, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Shiono Y, Arao M, Ukai K, Ito H, Watanabe K, Yoshioka K. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol 2002; 97: 133-137
28. Sartori M, Andorno S, Rigamonti C, Grossini E, Nicosia G, Boldorini R. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol 2000; 15: 1411-1417
29. Shedlofsky SI. Role of iron in the natural history and clinical course of hepatitis C disease. Hepatogastroenterology 1998; 45: 349-355
30. Fargion S, Fracanzani AL, Rossini A, Borzio M, Riggio O, Belloni G, Bissoli F, Ceriani R, Ballare M, Massari M, Trischitta C, Fiore P, Orlandi A, Morini L, Mattioli M, Oldani S, Cesana B, Fiorelli G. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Am J Gastroenterol 2002; 97: 1204 -1210
31. Streiff MB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 2002; 35: 947-952
32. Pianko S, McHutchison JG, Gordon SC, Heaton S, Goodman ZD, Patel K, Cortese CM, Brunt EM, Bacon BR, Blatt LM. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection. J Interferon Cytokine Res 2002; 22: 483-489
33. Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D. Experimental colitis in rats with portal hypertension and liver disease. Inflamm Bowel Dis 2003; 9:18-24
34. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
35. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209
36. Torrance JD, Bothwell TH. A simple technique for measuring storage iron concentrations in formalinised liver samples. S Afr J Med Sci 1968; 33: 9-11
37. WOESSNER JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-447
38. Sadrzadeh SM, Hallaway PE, Nanji AA. The long-acting parenteral iron chelator, hydroxyethyl starch-deferoxamine, fails to protect against alcohol induced liver injury in rats. J Pharmacol Exp Ther 1997; 280: 1038-1042
39. Andrews FJ, Morris CJ, Kondratowicz G, Blake DR. Effect of iron chelation on inflammatory joint disease. Ann Rheum Dis 1987; 46: 327-333
40. Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 1999; 5: 253-261
41. Stuart KA, Anderson GJ, Frazer DM, Murphy TL, Powell LW, Fletcher LM, Crawford DH. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis. Hepatology 2004; 39: 492-499
42. Medeiros DM, Beard JL. Dietary iron deficiency results in cardiac eccentric hypertrophy in rats. Proc Soc Exp Biol Med 1998; 218: 370-375
43. Hercberg S, Galan P. Biochemical effects of iron deprivation. Acta Paediatr Scand Suppl 1989; 361: 63-70
44. Lee WC, Lin HC, Hou MC, Lee FY, Chang FY, Tsai YT, Lee SD. Effect of anaemia on haemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 1999; 14: 370-375
45. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001; 121: 148-155
46. Hisakawa N, Nishiya K, Tahara K, Matsumori A, Hashimoto K. Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts. Ann Rheum Dis 1998; 57: 742-746
47. Sakuma S, Fujimoto Y, Miyata Y, Ohno M, Nishida H, Fujita T. Effects of Fe(2+), Zn(2+), Cu(2+) and Se(4+) on the synthesis and catabolism of prostaglandins in rabbit gastric antral mucosa. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 193-197
48. Laffi G, Carloni V, Baldi E, Rossi ME, Azzari C, Gresele P, Marra F, Gentilini P. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterology 1993; 105: 170-177
49. Smith JW, Castro GA. Relation of peroxidase activity in gut mucosa to inflammation. Am J Physiol 1978; 234: R72-R79
50. Swain MG, Tjandra K, Kanwar S, Kubes P. Neutrophil adhesion is impaired in rat model of cholestasis. Gastroenterology 1995; 109: 923-932
51. Roughneen PT, Drath DB, Kulkarni AD, Rowlands BJ. Impaired nonspecific cellular immunity in experimental cholestasis. Ann Surg 1987; 206: 578-582
52. Roughneen PT, Drath DB, Kulkarni AD, Kumar SC, Andrassy RJ, Rowlands BJ. Inflammatory cell function in young rodents with experimental cholestasis: Investigations of functional deficits, their etiology, and their reversibility. J Pediatr Surg 1989; 24: 668-673
53. Levy R, Schlaeffer F, Keynan A, Nagauker O, Yaari A, Sikuler E. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 1993; 17: 908-914
54. Murakawa H, Bland CE, Willis WT, Dallman PR. Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood 1987; 69: 1464-1468
55. Andrews FJ, Morris CJ, Lewis EJ, Blake DR. Effect of nutritional iron deficiency on acute and chronic inflammation. Ann Rheum Dis 1987; 46: 859-865